Peroxisome proliferator-activated receptor-γ ligands as cell-cycle modulators

被引:132
作者
Theocharis, S
Margeli, A
Vielh, P
Kouraklis, G
机构
[1] Univ Athens, Sch Med, Dept Forens Med & Toxicol, GR-11527 Athens, Greece
[2] Inst Curie, Dept Tumor Biol, Unit Cytol & Cytometry, Med Sect, F-75231 Paris 05, France
[3] Aghia Sophia Childrens Hosp, Dept Clin Biochem, GR-11527 Athens, Greece
[4] Univ Athens, Sch Med, Laikon Hosp, Dept Surg, GR-11527 Athens, Greece
关键词
PPAR-gamma ligands; cell cycle; apoptosis; cancer; treatment;
D O I
10.1016/j.ctrv.2004.04.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors, initially described as molecular targets for compounds which induce peroxisomal proliferation. PPAR-gamma, the best characterized of the PPARs, is a ligand-activated transcription factor and a key regulator of adipogenic differentiation and glucose homeostasis. PPAR-gamma ligands have recently been demonstrated to affect proliferation, differentiation and apoptosis of different cell types. Recent in vitro and in vivo studies suggest the importance of specific PPAR-gamma ligands as cell-cycle modulators, establishing their antineoplastic properties. In this review, the latest knowledge on the role of PPAR-gamma ligands as cell-cycle modulators is presented, discussing also their role in cell proliferation, apoptosis and cancer. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:545 / 554
页数:10
相关论文
共 88 条
[1]   PPAR gamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A [J].
Altiok, S ;
Xu, M ;
Spiegelman, BM .
GENES & DEVELOPMENT, 1997, 11 (15) :1987-1998
[2]  
Asou H, 1999, INT J ONCOL, V15, P1027
[3]   Peroxisome proliferator-activated receptor gamma (PPARγ) activation and its consequences in humans [J].
Bar-Tana, J .
TOXICOLOGY LETTERS, 2001, 120 (1-3) :9-19
[4]   Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation [J].
Blanquart, C ;
Barbier, O ;
Fruchart, JC ;
Staels, B ;
Glineur, C .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 85 (2-5) :267-273
[5]   A non-thiazolidinedione partial peroxisome proliferator-activated receptor γ ligand inhibits vascular smooth muscle cell growth [J].
Bruemmer, D ;
Berger, JP ;
Liu, J ;
Kintscher, U ;
Wakino, S ;
Fleck, E ;
Moller, DE ;
Law, RE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 466 (03) :225-234
[6]   Differential activation of peroxisome proliferator-activated receptor-γ by troglitazone and rosiglitazone [J].
Camp, HS ;
Li, O ;
Wise, SC ;
Hong, YH ;
Frankowski, CL ;
Shen, XQ ;
Vanbogelen, R ;
Leff, T .
DIABETES, 2000, 49 (04) :539-547
[7]  
Chang TH, 2002, CLIN CANCER RES, V8, P1206
[8]  
Chattopadhyay N, 2000, J NEUROSCI RES, V61, P67, DOI 10.1002/1097-4547(20000701)61:1<67::AID-JNR8>3.0.CO
[9]  
2-7
[10]   PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation [J].
Chawla, A ;
Barak, Y ;
Nagy, L ;
Liao, D ;
Tontonoz, P ;
Evans, RM .
NATURE MEDICINE, 2001, 7 (01) :48-52